By Michael McDevitt, MD, PhD

2008-12-08

The translational researcher of the future will need to understand and direct research in both the European and U.S. systems. In an effort to foster this global research, the European Hematology Association (EHA) and the American Society of Hematology (ASH) are pleased to announce a new joint training program in translational research, which will be based in Europe. This program, patterned after ASH’s successful Clinical Research Training Institute (CRTI), will launch in March 2010 with a one-week intensive training course.

In its inaugural year, the Translational Research Training in Hematology (TRTH) program will award 20 promising translational researchers an opportunity to work with hematology experts. Program modules will include didactic sessions on topics such as how to design phase I and II clinical trials, animal models for translational research, and diagnostics and biomarkers in translational research. Practical sessions will focus on career development, featuring career retrospectives from leaders in the field of hematology and sessions on hypothesis-driven research, expert opinions regarding opportunities in translational research, and panel discussions about grant preparation and funding sources.

TRTH is an exciting initiative that draws on the strengths of both EHA and ASH to train promising investigators in the translational research of tomorrow. Applications will be available in June 2009.

back to top